55 Randomized phase II clinical trial of cetuximab in combination with cisplatin (C) and vinorelbine (V) or CV alone in patients with advanced epidermal growth factor receptor (EGFR)-expressing non-small-cell lung cancer (NSCLC)

✍ Scribed by R. Rosell; R. Ramlau; A. Szczesna; C. Daniel; M. Bertrand; R. Garcia-Arroyo; K. O'Byrne; I. Montaner; M. Mueser; U. Gatzemeier

• Book ID: 118620232
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 168 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90090-5